Investigation of cytotoxic properties of some isoindole-related compounds bearing silyl and azide groups with in vitro and in silico studies

References

• Vitaku, E.; Smith, D. T.; Njardarson, J. T. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles Among US FDA Approved Pharmaceuticals: Miniperspective. J. Med. Chem. 2014, 57, 10257–10274. DOI: 10.1021/jm501100b.
   PubMed Web of Science ®Google Scholar
• Kochanowska-Karamyan, A. J.; Hamann, M. T. Marine İndole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety. Chem. Rev. 2010, 110, 4489–4497. DOI: 10.1021/cr900211p.
   PubMed Web of Science ®Google Scholar
• Odom, A. L.; McDaniel, T. J. Titanium-Catalyzed Multicomponent Couplings: Efficient One-Pot Syntheses of Nitrogen Heterocycles. Acc. Chem. Res. 2015, 48, 2822–2833. DOI: 10.1021/acs.accounts.5b00280.
   PubMed Web of Science ®Google Scholar
• Sang, P.; Xie, Y.; Zou, J.; Zhang, Y. Copper-Catalyzed Sequential Ullmann N-Arylation and Aerobic Oxidative C–H Amination: A Convenient Route to Indolo [1, 2-c] Quinazoline Derivatives. Org. Lett. 2012, 14, 3894–3897. DOI: 10.1021/ol3016435.
   PubMed Web of Science ®Google Scholar
• Singh, P.; Singh, J.; Pant, G. J.; Rawat, M. S. 2-Pyrazolines as Biologically Active and Fluorescent Agents, an Overview. Anticancer Agents Med. Chem. 2018, 18, 1366–1385. DOI: 10.2174/1871520618666180313153407.
   PubMed Web of Science ®Google Scholar
• Pen-Yuan, L.; Sheng-Jie, S.; Hsien-Liang, S.; Hsue-Fen, C.; Chiung-Chang, L.; Pong-Chun, L.; Leng-Fang, W. A Simple Procedure for Preparation of N-Thiazolyl and N-Thiadiazolylcantharidinimides and Evaluation of Their Cytotoxicities against Human Hepatocellular Carcinoma Cells. Bioorg. Chem. 2000, 28, 266–272. DOI: 10.1006/bioo.2000.1178.
   PubMed Web of Science ®Google Scholar
• Kumari, A.; Singh, R. K. Morpholine as Ubiquitous Pharmacophore in Medicinal Chemistry: Deep İnsight into the Structure-Activity Relationship (SAR). Bioorg. Chem. 2020, 96, 103578. DOI: 10.1016/j.bioorg.2020.103578.
   PubMed Web of Science ®Google Scholar
• Kerru, N.; Gummidi, L.; Maddila, S.; Gangu, K. K.; Jonnalagadda, S. B. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications. Molecules 2020, 25, 1909. DOI: 10.3390/molecules25081909.
   PubMed Web of Science ®Google Scholar
• Kumari, A.; Singh, R. K. Medicinal Chemistry of İndole Derivatives: Current to Future Therapeutic Prospectives. Bioorg. Chem. 2019, 89, 103021. DOI: 10.1016/j.bioorg.2019.103021.
   PubMed Web of Science ®Google Scholar
• Sethi, N. S.; Prasad, D. N.; Singh, R. K. An Insight into the Synthesis and SAR of 2,4-Thiazolidinediones (2,4-TZD) as Multifunctional Scaffold: A Review. Mini Rev. Med. Chem. 2020, 20, 308–330. DOI: 10.2174/1389557519666191029102838.
   PubMed Web of Science ®Google Scholar
• Heravi, M. M.; Zadsirjan, V. Prescribed Drugs Containing Nitrogen Heterocycles: An Overview. RSC Adv. 2020, 10, 44247–44311. DOI: 10.1039/D0RA09198G.
   PubMed Web of Science ®Google Scholar
• Mujagić, H.; Chabner, B. A.; Mujagić, Z. Mechanisms of Action and Potential Therapeutic Uses of Thalidomide. Croat. Med. J. 2002, 43, 274–285.
   PubMed Web of Science ®Google Scholar
• Dhiman, A.; Sharma, R.; Singh, R. K. Target-Based Anticancer İndole Derivatives and İnsight into Structure–Activity Relationship: A Mechanistic Review Update (2018–2021). Acta Pharm. Sin. B 2022, 12, 3006–3027. DOI: 10.1016/j.apsb.2022.03.021.
   PubMed Web of Science ®Google Scholar
• Lamie, P. F.; Phillopes, J. N.; El-Gendy, A. O.; Rarova, L.; Gruz, J. Design, Synthesis and Evaluation of Novel Phthalimide Derivatives as in Vitro anti-Microbial, anti-Oxidant and anti-İnflammatory Agents. Molecules 2015, 20, 16620–16642. DOI: 10.3390/molecules200916620.
   PubMed Web of Science ®Google Scholar
• Wu, J.-Y.; Kuo, C.-D.; Chu, C.-Y.; Chen, M.-S.; Lin, J.-H.; Chen, Y.-J.; Liao, H.-F. Synthesis of Novel Lipophilic N-Substituted Norcantharimide Derivatives and Evaluation of Their Anticancer Activities. Molecules 2014, 19, 6911–6928. DOI: 10.3390/molecules19066911.
   PubMed Web of Science ®Google Scholar
• Kok, S. H. L.; Chui, C. H.; Lam, W. S.; Chen, J.; Lau, F. Y.; Wong, R. S. M.; Cheng, G. Y. M.; Lai, P. B. S.; Leung, T. W. T.; Yu, M. W. Y. Synthesis and Structure Evaluation of a Novel Cantharimide and İts Cytotoxicity on SK-Hep-1 Hepatoma Cells. Bioorg. Med. Chem. Lett. 2007, 17, 1155–1159. DOI: 10.1016/j.bmcl.2006.12.039.
   PubMed Web of Science ®Google Scholar
• Hill, T. A.; Stewart, S. G.; Ackland, S. P.; Gilbert, J.; Sauer, B.; Sakoff, J. A.; McCluskey, A. Norcantharimides, Synthesis and Anticancer Activity: Synthesis of New Norcantharidin Analogues and Their Anticancer Evaluation. Bioorg. Med. Chem. 2007, 15, 6126–6134. DOI: 10.1016/j.bmc.2007.06.034.
   PubMed Web of Science ®Google Scholar
• Hill, T. A.; Stewart, S. G.; Sauer, B.; Gilbert, J.; Ackland, S. P.; Sakoff, J. A.; McCluskey, A. Heterocyclic Substituted Cantharidin and Norcantharidin Analogues—Synthesis, Protein Phosphatase (1 and 2A) İnhibition, and anti-Cancer Activity. Bioorg. Med. Chem. Lett. 2007, 17, 3392–3397. DOI: 10.1016/j.bmcl.2007.03.093.
   PubMed Web of Science ®Google Scholar
• Lin, L.-H.; Huang, H.-S.; Lin, C.-C.; Lee, L.-W.; Lin, P.-Y. Effects of Cantharidinimides on Human Carcinoma Cells. Chem. Pharm. Bull. (Tokyo) 2004, 52, 855–857. DOI: 10.1248/cpb.52.855.
   PubMed Web of Science ®Google Scholar
• Köse, A.; Bal, Y.; Kishalı, N. H.; Şanlı-Mohamed, G.; Kara, Y. Synthesis and Anticancer Activity Evaluation of New İsoindole Analogues. Med. Chem. Res. 2017, 26, 779–786. DOI: 10.1007/s00044-017-1793-1.
   Google Scholar
• Tan, A.; Yaglioglu, A. S.; Kishali, N. H.; Sahin, E.; Kara, Y. Evaluation of Cytotoxic Potentials of Some İsoindole-1, 3-Dione Derivatives on HeLa, C6 and A549 Cancer Cell Lines. Med. Chem. 2020, 16, 69–77. DOI: 10.2174/1573406415666181206115638.
   PubMed Web of Science ®Google Scholar
• Tan, A.; Koc, B.; Sahin, E.; Kishali, N. H.; Kara, Y. Synthesis of New Cantharimide Analogues Derived from 3-Sulfolene. Synthesis 2011, 2011, 1079–1084. DOI: 10.1055/s-0030-1258466.
   Google Scholar
• Tan, A.; Kizilkaya, S.; Kelestemur, U.; Akdemir, A.; Kara, Y. The Synthesis, Anticancer Activity, Structure-Activity Relationships and Molecular Modelling Studies of Novel İsoindole-1, 3 (2H)-Dione Compounds Containing Different Functional Groups. Anticancer Agents Med. Chem. 2020, 20, 1368–1378. DOI: 10.2174/1871520620666200410080648.
   PubMed Web of Science ®Google Scholar
• Tacke, R.; Heinrich, T.; Bertermann, R.; Burschka, C.; Hamacher, A.; Kassack, M. U. Sila-Haloperidol: A Silicon Analogue of the Dopamine (D2) Receptor Antagonist Haloperidol. Organometallics 2004, 23, 4468–4477. DOI: 10.1021/om040067l.
   Web of Science ®Google Scholar
• Barnes, M. J.; Conroy, R.; Miller, D. J.; Mills, J. S.; Montana, J. G.; Pooni, P. K.; Showell, G. A.; Walsh, L. M.; Warneck, J. B. H. Trimethylsilylpyrazoles as Novel İnhibitors of p38 MAP Kinase: A New Use of Silicon Bioisosteres in Medicinal Chemistry. Bioorg. Med. Chem. Lett. 2007, 17, 354–357. DOI: 10.1016/j.bmcl.2006.10.044.
   PubMed Web of Science ®Google Scholar
• Tacke, R.; Handmann, V. I.; Bertermann, R.; Burschka, C.; Penka, M.; Seyfried, C. Sila-Analogues of High-Affinity, Selective σ Ligands of the Spiro[İndane-1,4‘-Piperidine] Type: Syntheses, Structures, and Pharmacological Properties. Organometallics 2003, 22, 916–924. DOI: 10.1021/om020354u.
   Web of Science ®Google Scholar
• Franz, A. K.; Wilson, S. O. Organosilicon Molecules with Medicinal Applications. J. Med. Chem. 2013, 56, 388–405. DOI: 10.1021/jm3010114.
   PubMed Web of Science ®Google Scholar
• Ramesh, R.; Reddy, D. S. Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds. J. Med. Chem. 2018, 61, 3779–3798. DOI: 10.1021/acs.jmedchem.7b00718.
   PubMed Web of Science ®Google Scholar
• Kitel, R.; Byczek-Wyrostek, A.; Hopko, K.; Kasprzycka, A.; Walczak, K. Effect of Selected Silyl Groups on the Anticancer Activity of 3,4-Dibromo-5-Hydroxy-Furan-2(5H)-One Derivatives. Pharmaceuticals 2021, 14, 1079. DOI: 10.3390/ph14111079.
   Web of Science ®Google Scholar
• Kılıç Süloğlu, A.; Selmanoglu, G.; Gündoğdu, Ö.; Kishalı, N. H.; Girgin, G.; Palabıyık, S.; Tan, A.; Kara, Y.; Baydar, T. Evaluation of İsoindole Derivatives: Antioxidant Potential and Cytotoxicity in the HT‐29 Colon Cancer Cells. Arch. Pharm. 2020, 353, 2000065. DOI: 10.1002/ardp.202000065.
   Web of Science ®Google Scholar
• Tan, A.; Koç, B.; Kishalı, N.; Şahin, E.; Kara, Y. Synthesis of New Hexahydro-1H-İsoindole-1, 3 (2H)-Dione Derivatives from 2-Ethyl/Phenyl-3a, 4, 7, 7a-Tetrahydro-1H-İsoindole-1, 3-(2H)-Dion. Turk. J. Chem. 2016, 40, 830–840. DOI: 10.3906/kim-1511-66.
   Web of Science ®Google Scholar
• Philoppes, J. N.; Lamie, P. F. Design and Synthesis of New Benzoxazole/Benzothiazole-Phthalimide Hybrids as Antitumor-Apoptotic Agents. Bioorg. Chem. 2019, 89, 102978. DOI: 10.1016/j.bioorg.2019.102978.
   PubMed Web of Science ®Google Scholar
• Köse, A.; Kaya, M.; Kishalı, N. H.; Akdemir, A.; Şahin, E.; Kara, Y.; Şanlı-Mohamed, G. Synthesis and Biological Evaluation of New Chloro/Acetoxy Substituted İsoindole Analogues as New Tyrosine Kinase İnhibitors. Bioorg. Chem. 2020, 94, 103421. DOI: 10.1016/j.bioorg.2019.103421.
   PubMed Web of Science ®Google Scholar
• Ballou, L. M.; Lin, R. Z. Rapamycin and mTOR Kinase İnhibitors. J. Chem. Biol. 2008, 1, 27–36. DOI: 10.1007/s12154-008-0003-5.
   PubMedGoogle Scholar
• Matter, M. S.; Decaens, T.; Andersen, J. B.; Thorgeirsson, S. S. Targeting the mTOR Pathway in Hepatocellular Carcinoma: Current State and Future Trends. J. Hepatol. 2014, 60, 855–865. DOI: 10.1016/j.jhep.2013.11.031.
   PubMed Web of Science ®Google Scholar
• Chaube, U.; Chhatbar, D.; Bhatt, H. 3D-QSAR, Molecular Dynamics Simulations and Molecular Docking Studies of Benzoxazepine Moiety as mTOR İnhibitor for the Treatment of Lung Cancer. Bioorg. Med. Chem. Lett. 2016, 26, 864–874. DOI: 10.1016/j.bmcl.2015.12.075.
   PubMed Web of Science ®Google Scholar
• Richardson, C. J.; Bröenstrup, M.; Fingar, D. C.; Jülich, K.; Ballif, B. A.; Gygi, S.; Blenis, J. SKAR is a Specific Target of S6 Kinase 1 in Cell Growth Control. Curr. Biol. 2004, 14, 1540–1549. DOI: 10.1016/j.cub.2004.08.061.
   PubMed Web of Science ®Google Scholar
• Wang, Y.; Mei, H.; Shao, Q.; Wang, J.; Lin, Z. Association of Ribosomal Protein S6 Kinase 1 with Cellular Radiosensitivity of Non-Small Lung Cancer. Int. J. Radiat. Biol. 2017, 93, 581–589. DOI: 10.1080/09553002.2017.1294273.
   PubMed Web of Science ®Google Scholar
• Bahrami-B, F.; Ataie-Kachoie, P.; Pourgholami, M. H.; Morris, D. L. p70 Ribosomal Protein S6 Kinase (Rps6kb1): An Update. J. Clin. Pathol. 2014, 67, 1019–1025. DOI: 10.1136/jclinpath-2014-202560.
   PubMed Web of Science ®Google Scholar
• Iqbal, N.; Iqbal, N. Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic İmplications. Mol. Biol. Int. 2014, 2014, 1–9. DOI: 10.1155/2014/852748.
   Google Scholar
• Holbro, T.; Civenni, G.; Hynes, N. E. The ErbB Receptors and Their Role in Cancer Progression.Exp. Cell Res. 2003, 284, 103–114. DOI: 10.1016/B978-012160281-9/50009-8.
   Web of Science ®Google Scholar
• Mosmann, T. Rapid Colorimetric Assay for Cellular Growth and Survival: application to Proliferation and Cytotoxicity Assays. J. Immunol. Methods 1983, 65, 55–63. DOI: 10.1016/0022-1759(83)90303-4.
   PubMed Web of Science ®Google Scholar
• Freshney, R. I.; Freshney, M. G. Culture of Epithelial Cells; New York: Wiley-Liss, 2002; Vol. 195. DOI: 10.1002/0471221201.
   Google Scholar
• Kaya, M. Investigation of Anticancer Properties of the Novel Synthesized Pyrrole Derivatives as Potential Tyrosine Kinase Inhibitors. M.S. Thesis, Izmir Institute of Technology (Turkey), 2016.
   Google Scholar
• Berman, H.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.; Weissig, H.; Shindyalov, I.; Bourne, P. The Protein Data Bank. Nucleic Acids Res. 2000, 28, 235–242. URL: www.rcsb.org Citation. DOI: 10.1093/nar/28.1.235.
   Google Scholar
• Biovia, D. S. Discovery Studio 2019; Dassault Systèmes: San Diego, 2019. 2021
   Google Scholar
• Hanwell, M. D.; Curtis, D. E.; Lonie, D. C.; Vandermeersch, T.; Zurek, E.; Hutchison, G. R. Avogadro: An Advanced Semantic Chemical Editor, Visualization, and Analysis Platform. J. Cheminform. 2012, 4, 17. DOI: 10.1186/1758-2946-4-17.
   PubMed Web of Science ®Google Scholar
• Morris, G. M.; Huey, R.; Lindstrom, W.; Sanner, M. F.; Belew, R. K.; Goodsell, D. S.; Olson, A. J. AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility. J. Comput. Chem. 2009, 30, 2785–2791. DOI: 10.1002/jcc.21256.
   PubMed Web of Science ®Google Scholar
• Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual Molecular Dynamics. J. Mol. Graph. 1996, 14, 33–38. DOI: 10.1016/0263-7855(96)00018-5.
   PubMed Web of Science ®Google Scholar